ABSTRACT
Background Sacral dysmorphism refers to morphological variations found in the first two sacral segments that limit the safe placement of percutaneous sacral iliac screws. The prevalence is documented in European, North American and some Asian populations. However, studies within the African population including Kenya are lacking. The aim of the study was to describe the patterns of sacral dysmorphism in pelvic computerized tomography (CT) scans at a national referral hospital in Kenya.
Methods A cross-sectional study carried out at the Radiology Department, Kenyatta National Hospital from March 2020 to March 2021 involving the radiographic evaluation of 293 stored abdominal pelvic CT scans of patients. Sacral dysmorphism was identified based on the sacral dysmorphism score >70 and the presence of any of the six morphological features of sacral dysmorphism.
Results A sacral dysmorphism score of more than 70 was found to in 64% of the population. The prevalence of dysmorphic sacra (based on the presence of at least one qualitative feature) was 100%. The most prevalent feature of sacral dysmorphism was the lack of recession of the S1 segment (82%) followed by an unfused sacral segment (76%). Of note is that some qualitative features of sacral dysmorphism were protective against a high sacral dysmorphism score. There was no statistical significance of gender in sacral dysmorphism.
Conclusion There is a high prevalence of sacral dysmorphism score in this population. There is a need for further studies to revisit the concept of dysmorphic sacra based on the presence of at least one qualitative feature as all our participants had at least one feature.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The author(s) received no specific funding for this work.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study was approved by Kenyatta National Hospital-University of Nairobi Ethics and Research Committee (KNH-UON ERC) approval number KNH-ERC/A/9 as required by the Department of Surgery, Orthopaedic Unit Faculty of Health Sciences, University of Nairobi. The study was also approved by the National Commission for Science Technology and Innovation NACOSTI reference NACOSTI/P/22/15319.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All relevant data are within the manuscript and its Supporting Information files.
